OVERVIEW
TEAM
Our mission is to discover, develop and deliver innovative therapeutics
for patients suffering from cancer and other incurable diseases.
-
DR. HYUNHEE KWAK CEO
EDUCATION
- College of Pharmacy, Seoul National University, M.S. (1990~1992), Ph.D. (2005~2010)
- College of Pharmacy, Ewha Woman’s University, B.S. (1986-1990)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, CEO (2019~present)
- Research Institute, Dong-A Socio Holdings, Director/Head of Biologics Res. Lab. (2015~2019)
- Research Institute, Dong-A Pharmaceuticals, Senior Research Scientist (1992~2014)
-
DR. HYUN SEOK KIM FOUNDER & CTO
EDUCATION
- University of Texas Southwestern Medical Center, Postdoc (2008~2014)
- Washington University in St. Louis, Computational Biology, Ph.D. (2003~2008)
- Department of Microbiology, Seoul National University, B.S, M.S. (1991~1997)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, CTO (2019~present)
- Yonsei University College of Medicine, Assistant professor, Associate professor (2014~present)
- R&D Center of Pharmaceuticals, CJ Institute of Science & Technology, Research Scientist (1997~2003)
-
JOOYOUNG LEE BIOLOGY, DIRECTOR
EDUCATION
- Division of Life and Pharmaceutical Sciences, Ewha Woman’s University, M.S. (2005~2007), Ph.D. (2008~2012)
- Department of life science, Ewha Woman’s University, B.S. (2001-2005)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, Director (2020~present)
- Yonsei University College of Medicine, Assistant research professor (2018~2019)
- Yonsei University College of Medicine, Postdoctal fellow (2014~2017)
-
LIM JONG WON BIOLOGY, DIRECTOR
EDUCATION
- Fred Hutchinson Cancer Research Center, Postdoc (2011~2018)
- Washington University in St. Louis, Postdoc (2008-2011)
- Washington University in St. Louis, Developmental Biology, Ph.D. (2002~2008)
- Department of Microbiology, Seoul National University, B.S. (1994~1998)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, Director (2021~present)
- Universal Cells (An Astellas Company), Scientist II (2018~2020)
-
SEUNGWAN KANG MEDICINAL CHEMISTRY, DIRECTOR
EDUCATION
- Department of Chemistry, Korea University, M.S. (2002-2004)
- Department of Chemistry, Korea University, B.S. (1995-2002)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, Director, Head of Development Department (2020~present)
- Drug Discovery Center, Life Sciences R&D, LG Chem, Senior Research Scientist (2017~2019)
- Drug Discovery R&D Center, LG Life Sciences, Senior Research Scientist (2004~2016)
-
LEE SAE YEON CMC, DIRECTOR
EDUCATION
- Division of Science in Organic Chemistry, Hanyang University / Korea Institute of Science and Technology, Master (2005 – 2007)
- Division of Science in Chemistry, Gachon University, B.S. (1997 – 2005)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, Director (2021~present)
- Independent CMC consultant (2019 – 2021)
- Nano PharmaSolutions Inc., Co-founder, Chief Operating Officer (2019 – 2021)
- Qurient Co. Ltd., Team head of CMC development
(2012 – 2019) - Institut Pasteur Korea, Researcher II (2007-2012)
-
KIM SONG WON CFO
EDUCATION
- Department of Business Administration, Chung Ang University, B.S (1988~1992)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, CFO (2021~present)
- Neuracle Science, CFO (2015~2021)
- Eyegene, CFO (2014~2015)
- NEW, CFO (2008~2013)
- Helixmith, Acounting Manager (2002~2007)
- Terasource VC, Accounting Manager (2000~2001)
- Hotel Intercontinental Seoul, Accountant (1995~2000)